GENOCEA BIOSCIENCES, INC.: cashflow_investing
| Value | {"amount": -3208000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | GENOCEA BIOSCIENCES, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:23:53.831879+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2f40ebaf-3fc1-4cc0-b206-4a2e41874612
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001457612-22-000039 · Open the official SEC filing →Retrieved: 2026-08-19T14:23:53.831879+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001457612/cashflow-investing/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2f40ebaf-3fc1-4cc0-b206-4a2e41874612
History
- no predecessors — first report